ElectroCore, LLC (electroCore), a commercial-stage bioelectronic medicine company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an expanded label for gammaCore® (nVNS) as an acute treatment of pain associated with migraine in adult patients.
gammaCore therapy is a proprietary, non-invasive neuromodulation treatment delivered by a hand-held unit that stimulates the vagus nerve through the skin. This follows the initial FDA clearnance receieved by gammaCore for…